Effect of noninvasive neuromodulation in the menopusal period in women

Abstract

In women with extragenital pathology in the menopausal period, the use of noninvasive neuromodulation for the treatment of psychovegetative disorders has been proposed. The method allows to reduce the severity of menopausal and psychosomatic (depression, anxiety) disorders and the level of their mutual influence.

Keywords

noninvasive neuromodulation / trascranial electrotherapy / climacteric frustration

References

[1] Balan V.E. Urogenital disorders in menopause (clinic, diagnosis, replacement therapy: dis doct. med. sci. Moscow, 1998. 253 p. (In Russ.)

[2] Балан В.Е. Урогенитальные расстройства в климактерии (клиника, диагностика, заместительная терапия: дис. … докт. мед. наук. М., 1998. 253 с.

[3] Voropaev A.A., Gerasimenko M.Yu., Rachin A.P. Application of transcranial electrostimulation in patients with depressive anxiety disorders. Fizioterapiya, Bal’neologiya i Reabilitatsiya (Russian Journal of the Physical Therapy, Balneotherapy and Rehabilitation). 2016; 1(5): 244. (In Russ.)

[4] Воропаев А.А., Герасименко М.Ю., Рачин А.П. Примение транскраниальной электростимуляции у больных с депрессивно-тревожными расстройствами. Физиотерапия, бальнеология и реабилитация. 2016; 15(5): 244.

[5] Zaidiyev Ya.Z. Hormone prevention and correction of systemic disorders in women in perimenopause: dis. Dr. med. sci. Moscow, 1997. 279 p. (In Russ.)

[6] Зайдиева Я.З. Гормонопрофилактика и коррекция системных нарушений у женщин в перименопаузе: дис. … докт. мед. наук. М., 1997. 279 с.

[7] Zaidieva Ya.Z. New treatment options for menopausal disorders in postmenopausal women. Ginekologiya. 2003; 5(1): 10–5. (In Russ.)

[8] Зайдиева Я.З. Новые возможности лечения климактерических расстройств в постменопаузе. Гинекология. 2003; 5(1): 10–5.

[9] Smetnik V.P. Clinical aspects of menopausal disorders. In: Proceedings of the conference «Hormonal therapy of menopausal disorders». Moscow, 1994: 4–8. (In Russ.)

[10] Сметник В.П. Клинические аспекты климактерических расстройств. В кн.: Материалы конференции «Гормональная терапия климактерических расстройств». М., 1994: 4–8.

[11] Crook D., Godsland I.F., Hull J. Hormone replacement therapy with dydrogesterone and 17β-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 months follow up. Br. J. Obstet. Gynecol. 1997; 104: 298–304.

[12] Crook D., Godsland I.F., Hull J. Hormone replacement therapy with dydrogesterone and 17ß-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up. Br. J. Obstet. Gynecol. 1997; 104: 298–304.

[13] Ducker, E.M., Kopansky, L., Jarry, H., Wuttke, W. Effect of extracts from Cimicifuga racemoza on rats. Planta Medica. 1991; 57: 420–4.

[14] Ducker E.M., Kopansky L., Jarry H., Wuttke W. Effect of extracts from Cimicifuga racemoza on gonadotropin release in menopausal women and ovarioectomized rats. Planta Medica. 1991; 57: 420–4.

[15] Siddle N., Jesinger D.K., Whitehead M.I. et al. Lipoproteins of postmenopausal estrogen therapy with added dydrogesterone. Br. J. Obstet. Gynaecol. 1990; 97: 1093-1100.

[16] Siddle N., Jesinger D.K., Whitehead M.I. et al. Effect on plasma lipids and lipoproteins of postmenopausal oestrogen therapy with added dydrogesterone. Br. J. Obstet. Gynaecol. 1990; 97: 1093-1100.

[17] Thorp J.M.Jr., Gavin N.J., Ohsfeldt R.L. Hormone replacement therapy in postmenopausal women: utilization of health care resources by new users. Am. J. Obstet. Gynecol. 2001; 185(2): 318–26.

[18] Thorp J.M.Jr., Gavin N.J., Ohsfeldt R.L. Hormone replacement therapy in postmenopausal women: utilization of health care resources by new users. Am. J. Obstet. Gynecol. 2001; 185(2): 318– 26.

[19] Jarry H., Harnischfeger G., Dücker E. Studies on the endocrine effects of the contents of Cimicifuga racemosa 2. In vitro binding of compounds to estrogen receptors. Planta Medica. 1985; 51(4): 316–9.

[20] Lohnung A., Verspohl E.J., Winterhoff H. Pharmacological studies on the dopaminergic activity of Cimicifuga racemoza. In: 23rd International LOF-Symposium on Phyto-Oestrogens. Gent, 1999.

[21] Marcus R. Skeletal effects of growth hormone and IGF-I in adults. Horm. Res. 1997; 48(Suppl 5): 60–4.

[22] Mijatovic V., Kenemans P., Netelenbos C. et al. Postmenopausal oral 17beta-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels. Fertil. Steril. 1998; 69(5): 876–82.

[23] Heikkinen J.E., Vaheri R.T., Ahomäki S.M. et al. Optimizing continuous-combined hormone replacement therapy for postmenopausal women: a comparison of six different treatment regimens. Am. J. Obstet. Gynecol. 2000; 182(3): 560–7.

[24] Fletcher C.D., Bulpitt C.J. Measurement of quality of life in ceinical trials therapy. Cardiology. 1987; (75, Suppl. 1): 44–52.

[25] Rosen C.J., Conover C. Growth hormone/insulin-like growth factor-I axis in aging: a summary of a National Institutes of Aging-Sponsored Symposium. J. Clin. Endocrinol. Metab. 1997; 82(12): 3919–22.

[26] Samsioe G. Medical and surgical strategies for treating urogynecological disorders. Int. J. Fertil. 1996; 41(2): 136–41.

[27] Voropaev A.A., Rudolf Sh. Transcranial electrostimulator (versions) and device for fastening transcranial electrostimulator electrodes. Patent RF N 2397253. 2003. (In Russ.)

[28] Воропаев А.А., Рудольф Ш. Электростимулятор транскраниальный (варианты) и устройство для крепления электродов электростимулятора транскраниального. Патент РФ № 2397253. 2003.

[29] Voropaev A.A., Mochalov A.D. The use of transcranial electrostimulation in chronic cerebrovascular insufficiency. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2006; 106(5): 31–4. (In Russ.)

[30] Воропаев А.А., Мочалов А.Д. Применение транскраниальной электростимуляции при хронической цереброваскулярной недостаточности. Журнал неврологии и психиатрии им. С.С. Корсакова. 2006; 106(5): 31–4.

[31] Voropaev A.A., Mochalov A.D., Kornakov G.N. The method of craniospinal electrotherapy and device for its implementation. Patent RF N 2264234. 2004. (In Russ.)

[32] Воропаев А.А., Мочалов А.Д., Корнаков Г.Н. Способ краниоспинальной электромагнитотерапии и устройство для ее реализации. Патент РФ № 2264234. 2004.

[33] Voropaev A.A., Mochalov A.D., Zhirnova E.V. A method for the treatment of vascular headaches. Patent RF N 2233677. 2002. (In Russ.)

[34] Воропаев А.А., Мочалов А.Д., Жирнова Е.В. Способ лечения сосудистых головных болей. Патент РФ № 2233677. 2002.

RIGHTS & PERMISSIONS

Eco-Vector